Economic aspects of the new Spanish laws on pharmaceutical preparations

被引：11

作者：

Antonanzas, Fernando ^{[1
]}

Oliva, Juan ^{[2
]}

Pinillos, Mariola ^{[1
]}

Juarez, Carmelo ^{[1
]}

机构：

[1] Univ La Rioja, Dept Econ & Business Adm, Logrono 26004, Spain

[2] Univ Castilla La Mancha, Fac Econ, Albacete, Spain

来源：

EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2007年 / 8卷 / 03期

关键词：

Generic Drug; Reference Price; Retail Price; Pharmaceutical Preparation; Drug Price;

D O I：

10.1007/s10198-007-0050-9

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

In this article, we provide readers with a summary of the main economic features of the recently approved Spanish law regarding pharmaceutical preparations entitled the Law of Guarantees and Rational Use of Pharmaceuticals and Health Products (Law 29/2006 of July 26th). We review information on pricing, reference pricing, promotion of generic drugs, public reimbursement, patients' contributions, and penalties. Other aspects of minor economic relevance such as the information on prices shown in the packs and the transparency on the results of clinical trials irrespective of whether these are positive or not, are not addressed in this paper. We conclude with some observations on the new horizons opened up by this new legal framework. We have not included my detailed references to the new law; we merely wish to comment on certain aspects of its application.

引用

页码：297 / 300

页数：4